Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California HIV testing initiatives “could serve as national models”

This article was originally published in Clinica

Executive Summary

The San Francisco AIDS Foundation has said it will be investing $400,000 on two projects aimed at the early detection of and subsequent therapy for acute HIV.

You may also be interested in...



US: The sun shines in on industry-doctor relationships

The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean

Global regulators/industry to gather in US and Germany to talk device regulation

Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.

Global regulators and industry execs to gather in US and Germany to talk device regulation

Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT042432

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel